161 related articles for article (PubMed ID: 769667)
1. Susceptibility of Mycobacterium leprae to dapsone as a determinant of patient response to acedapsone.
Levy L; Peters JH
Antimicrob Agents Chemother; 1976 Jan; 9(1):102-12. PubMed ID: 769667
[TBL] [Abstract][Full Text] [Related]
2. The number of Mycobacterium leprae in the pretreatment biopsy-specimen does not determine the rate of response of patients with lepromatous leprosy to chemotherapy with acedapsone.
Levy L; Shepard CC
Lepr Rev; 1986 Mar; 57(1):27-31. PubMed ID: 3517535
[No Abstract] [Full Text] [Related]
3. Blood dapsone levels in leprosy patients treated with acedapsone.
George J; Balakrishnan S
Indian J Lepr; 1986; 58(3):401-6. PubMed ID: 3794408
[TBL] [Abstract][Full Text] [Related]
4. Acedapsone (DADDS) treatment of leprosy patients in the Karimui of Papua New Guinea: status at six years.
Russell DA; Shepard CC; McRae DH; Scott GC; Vincin DR
Am J Trop Med Hyg; 1975 May; 24(3):485-95. PubMed ID: 1098496
[TBL] [Abstract][Full Text] [Related]
5. Acedapsone treatment of leprosy patients: response versus drug disposition.
Peters JH; Murray JF; Gordon GR; Levy L; Russell DA; Scott GC; Vincin DR; Shepard CC
Am J Trop Med Hyg; 1977 Jan; 26(1):127-36. PubMed ID: 842774
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of strains of Mycobacterium leprae isolated prior to 1977 from patients with previously untreated lepromatous leprosy.
Shepard CC; Rees RJ; Levy L; Pattyn SR; Baohong J; Dela Cruz EC
Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):11-5. PubMed ID: 3519796
[TBL] [Abstract][Full Text] [Related]
7. Bactericidal action of dapsone against Mycobacterium leprae in mice.
Levy L
Antimicrob Agents Chemother; 1976 Apr; 9(4):614-7. PubMed ID: 773300
[TBL] [Abstract][Full Text] [Related]
8. Minimal inhibitory concentration of dapsone for Mycobacterium leprae in rats.
Peters JH; Gordon GR; Murray JF; Fieldsteel AH; Levy L
Antimicrob Agents Chemother; 1975 Nov; 8(5):551-7. PubMed ID: 1108776
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous detection of Mycobacterium leprae and its susceptibility to dapsone using DNA heteroduplex analysis.
Williams DL; Pittman TL; Gillis TP; Matsuoka M; Kashiwabara Y
J Clin Microbiol; 2001 Jun; 39(6):2083-8. PubMed ID: 11376039
[TBL] [Abstract][Full Text] [Related]
10. Rifampin therapy of lepromatous leprosy.
Am J Trop Med Hyg; 1975 May; 24(3):475-84. PubMed ID: 1098495
[TBL] [Abstract][Full Text] [Related]
11. Dapsone resistance in Mycobacterium leprae.
Gillis TP; Williams DL
Lepr Rev; 2000 Dec; 71 Suppl():S91-5. PubMed ID: 11201896
[TBL] [Abstract][Full Text] [Related]
12. [Resistance of Mycobacterium leprae to dapsone and rifampicin: apropos of a survey carried out in the Cape Verde region (Senegal)].
Grosset J; Guelpa-Lauras CC; Millan J; Bodian M; Perani E
Med Trop (Mars); 1987; 47(2):171-5. PubMed ID: 3306248
[TBL] [Abstract][Full Text] [Related]
13. The death of Mycobacterium leprae during treatment with 4,4'-diaminodiphenylsulfone (DDS). Initial rate in patients.
Shepard CC; Levy L; Fasal P
Am J Trop Med Hyg; 1968 Sep; 17(5):769-75. PubMed ID: 4877714
[No Abstract] [Full Text] [Related]
14. A preliminary report on a therapeutic trial with acedapsone in lepromatous leprosy.
Ramanujam K; Iyer CG; Ramu G
Lepr Rev; 1975 Jun; 46(2 Suppl):85-7. PubMed ID: 1100969
[No Abstract] [Full Text] [Related]
15. Survey for secondary dapsone and rifampicin resistance in Cuba.
González AB; Maestre JL; Hernández O; Columbié Y; Atrio N; Martin M; Fernández AM; Rodríguez J
Lepr Rev; 1993 Jun; 64(2):128-35. PubMed ID: 8341115
[TBL] [Abstract][Full Text] [Related]
16. Combined rifampin and dapsone chemotherapy of Mycobacterium leprae infection of the neonatally thymectomized Lewis rat.
Fieldsteel AH; Levy L
Int J Lepr Other Mycobact Dis; 1980 Sep; 48(3):267-76. PubMed ID: 7002811
[TBL] [Abstract][Full Text] [Related]
17. Metabolism and interactions of antileprosy drugs.
George J
Biochem Pharmacol; 2020 Jul; 177():113993. PubMed ID: 32339493
[TBL] [Abstract][Full Text] [Related]
18. The death rate of Mycobacterium leprae during treatment of lepromatous leprosy with acedapsone (DADDS).
Shepard CC; Levy L; Fasal P
Am J Trop Med Hyg; 1972 Jul; 21(4):440-5. PubMed ID: 4559065
[No Abstract] [Full Text] [Related]
19. Drug sensitivity of M. leprae isolated from leprosy patients administered DDS for long period of time.
Murohashi T; Yoshida K
Acta Leprol; 1978; (73):13-28. PubMed ID: 108909
[TBL] [Abstract][Full Text] [Related]
20. Primary dapsone-resistant leprosy in Cebu, Philippines.
Guinto RS; Cellona RV; Fajardo TT; de la Cruz EC
Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):427-30. PubMed ID: 7042607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
